Knowledge Distillery

A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020.

Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment of high-risk outpatients with COVID-19 in developing countries are…

Acute ischemic stroke (AIS) is a known neurological complication in patients with respiratory symptoms of COVID-19 infection.

High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic respiratory failure and is widely applied in patients with COVID-19.

The acute clinical manifestations of COVID-19 are well characterized; however, its post-acute sequalae have not been comprehensively described.

Emerging SARS-CoV-2 variants have raised concerns about resistance to neutralizing antibodies elicited by previous infection or vaccination.

In this article the authors identified an emerging SARS-CoV-2 variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from…

Functional (psychogenic) movement disorders (FMDs) are conditions in which affected patients develop abnormal movements that are incongruous with…

COVID‐19 related acute neurological phenotypes are being increasingly recognized, with neurological complications reported in over 30% of hospitalized…

Mounting evidence supports an association between Guillain‐Barré syndrome spectrum (GBSs) and SARS‐CoV‐2 infection.

The objective of this retrospective cohort study was to quantify rates of organ specific dysfunction in individuals with COVID-19 after discharge from…

The objective of this living systematic review and network meta-analysis was to compare the effects of treatments for COVID-19.